Search

Your search keyword '"Couderc, M."' showing total 32 results
Start Over Author "Couderc, M." Publisher bmj
32 results on '"Couderc, M."'

1. POS1223 DIFFERENT ANTI-SARS-CoV-2 VACCINE RESPONSE UNDER B- AND T-CELL TARGETED THERAPIES VERSUS ANTI-CYTOKINE THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES

Author

Felten, R., primary, Geoffroy, M., additional, Loïs, B., additional, Duret, P. M., additional, Desmurs, M., additional, Fan, A., additional, Couderc, M., additional, Messer, L., additional, Ardizzone, M., additional, Ahmed-Yahia, S., additional, Javier, R. M., additional, Meyer, A., additional, Chatelus, E., additional, Sordet, C., additional, Pijnenburg, L., additional, Sibilia, J., additional, Soubrier, M., additional, Gottenberg, J. E., additional, and Salmon, J. H., additional

Published
2022
Full Text
View/download PDF

2. OP0127 UNFAVORABLE PREGNANCY OUTCOME IS SIGNIFICANTLY ASSOCIATED WITH CORTICOSTEROID EXPOSURE DURING PREGNANCY IN WOMEN WITH RHEUMATOID ARTHRITIS: ANALYSIS OF THE PROSPECTIVE GR2 COHORT

Author

Hamroun, S., primary, Couderc, M., additional, Flipo, R. M., additional, Gossec, L., additional, Richez, C., additional, Belkhir, R., additional, Frazier-Mironer, A., additional, Devauchelle-Pensec, V., additional, Marotte, H., additional, Sellam, J., additional, Gervais, E., additional, Deroux, A., additional, Lukas, C., additional, Dernis, E., additional, Chatelus, E., additional, Costedoat-Chalumeau, N., additional, and Moltó, A., additional

Published
2022
Full Text
View/download PDF

3. OP0153 PRECONCEPTIONAL NSAID TREATMENT IS ASSOCIATED WITH LONGER TIME-TO-CONCEPTION IN WOMEN WITH SPONDYLOARTHRITIS: ANALYSIS OF THE PROSPECTIVE GR2 COHORT

Author

Hamroun, S., primary, Couderc, M., additional, Flipo, R. M., additional, Sellam, J., additional, Richez, C., additional, Dernis, E., additional, Frazier-Mironer, A., additional, Gossec, L., additional, Gervais, E., additional, Marotte, H., additional, Dunogeant, L., additional, Lukas, C., additional, Deroux, A., additional, Costedoat-Chalumeau, N., additional, and Moltó, A., additional

Published
2022
Full Text
View/download PDF

4. POS1000 MORE THAN 30 % OF WOMEN WITH SPONDYLOARTHRITIS HAVE AN UNFAVORABLE PREGNANCY OUTCOME MOST FREQUENTLY DUE TO SMALL FOR GESTATIONAL AGE: ANALYSIS OF THE PROSPECTIVE GR2 COHORT

Author

Hamroun, S., primary, Couderc, M., additional, Flipo, R. M., additional, Sellam, J., additional, Richez, C., additional, Belkhir, R., additional, Gossec, L., additional, Marotte, H., additional, Dernis, E., additional, Frazier-Mironer, A., additional, Gervais, E., additional, Lukas, C., additional, Devauchelle-Pensec, V., additional, Dunogeant, L., additional, Deroux, A., additional, Costedoat-Chalumeau, N., additional, and Moltó, A., additional

Published
2022
Full Text
View/download PDF

7. POS0621 MORE THAN 40% OF WOMEN WITH RHEUMATOID ARTHRITIS HAVE A TIME-TO-CONCEPTION LONGER THAN 1 YEAR: ANALYSIS OF THE PROSPECTIVE GR2 COHORT

Author

Hamroun, S., primary, Couderc, M., additional, Gossec, L., additional, Flipo, R. M., additional, Marotte, H., additional, Richez, C., additional, Frazier-Mironer, A., additional, Sellam, J., additional, Gervais, E., additional, Devauchelle-Pensec, V., additional, Deroux, A., additional, Belkhir, R., additional, Dellal, A., additional, Dunogeant, L., additional, Lukas, C., additional, Chatelus, E., additional, Costedoat-Chalumeau, N., additional, and Moltó, A., additional

Published
2022
Full Text
View/download PDF

8. FRI0449 MANAGEMENT AND OUTCOME OF SEPTIC ARTHRITIS OF NATIVE JOINT: A NATIONWIDE SURVEY

Author

Richebé, P., primary, Godot, S., additional, Coiffier, G., additional, Guggenbuhl, P., additional, Mulleman, D., additional, Couderc, M., additional, Dernis, E., additional, Deprez, V., additional, Salliot, C., additional, Urien, S., additional, Brault, R., additional, Ruyssen-Witrand, A., additional, Hoppe, E., additional, Gottenberg, J. E., additional, Roux, C., additional, Ottaviani, S., additional, Breban, M., additional, Beaufrere, M., additional, Michaut, A., additional, Pauvele, L., additional, Darrieutort, C., additional, Wendling, D., additional, Coquerelle, P., additional, Bart, G., additional, Gervais, E., additional, Goeb, V., additional, Ardizzone, M., additional, Pertuiset, E., additional, Derolez, S., additional, Ziza, J. M., additional, Flipo, R. M., additional, and Seror, R., additional

Published
2020
Full Text
View/download PDF

14. FRI0186 Retention of First-Line anti-TNF Treatments and in Cases of Failure Retention Rates of anti-TNF Drug or A Non-TNF-Targeted Biologic in A Monocentric Cohort of 200 Rheumatoid Arthritis Patients

Author

Soubrier, M., primary, Pereira, B., additional, Tournadre, A., additional, Malochet-Guinamand, S., additional, Couderc, M., additional, Mathieu, S., additional, Tatar, Z., additional, Abdi, D., additional, Frayssac, T., additional, Fan, A., additional, and Dubost, J.-J., additional

Published
2016
Full Text
View/download PDF

19. FRI0233 Multireader Evaluation Could be an Alternative to Monoreader Evaluation and Improve Feasibility to Detect Radiographic Progression in Large Longitudinal Cohort of Rheumatoid Arthritis Patients (ESPOIR): Table 1

Author

Gandjbakhch, F., primary, Foltz, V., additional, Granger, B., additional, Jousse-Joulin, S., additional, Devauchelle, V., additional, Afshar, M., additional, Albert, J.D., additional, Bailly, F., additional, Constant, E., additional, Biale, L., additional, Milin, M., additional, Couderc, M., additional, Denarie, D., additional, Fradin, A., additional, Martaille, V., additional, Pierreisnard, A., additional, Poursac, N., additional, Saraux, A., additional, and Fautrel, B., additional

Published
2014
Full Text
View/download PDF

27. Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP).

Author

Meissner Y, Strangfeld A, Molto A, Forger F, Wallenius M, Costedoat-Chalumeau N, Bjørngaard H, Couderc M, Flipo RM, Guettrot-Imbert G, Haase I, Jakobsen B, Koksvik HSS, Richez C, Sellam J, Weiß A, Zbinden A, and Fischer-Betz R

Subjects
Adult, Cesarean Section, Data Analysis, Female, Humans, Infant, Newborn, Pregnancy, Registries, Severity of Illness Index, Treatment Outcome, Tumor Necrosis Factor Inhibitors, Tumor Necrosis Factor-alpha, Axial Spondyloarthritis, Premature Birth epidemiology, Rheumatology, Spondylarthritis drug therapy, Spondylitis, Ankylosing
Abstract

Objective: To investigate outcome and course of pregnancies in women with axial spondyloarthritis (axSpA) in a pooled data analysis of pregnancy registries in rheumatology., Methods: Prospectively followed women with axSpA, fulfilling ASAS classification criteria and for whom a pregnancy outcome was reported, were eligible for the analysis. Anonymised data of four registries was pooled. Rates of adverse pregnancy outcomes were calculated. Systemic inflammation, disease activity and treatment patterns with tumour necrosis factor inhibitor (TNFi) before, during and after pregnancy were analysed., Results: In a total of 332 pregnancies from 304 axSpA women, 98.8% of the pregnancies resulted in live birth. Mean maternal age was 31 years and disease duration 5 years. Most of these patients received pre-conception counselling (78.4%). Before pregnancy, 53% received TNFi treatment, 27.5% in first and 21.4% in third trimester. Pregnancy and neonatal outcomes were favourable with rates of 2.2% for pre-eclampsia, 4.9% for preterm birth, 3.1% for low birth weight and 9.5% for small for gestational age. Neonates were delivered by caesarean section in 27.7% of pregnancies, of which 47.4% were emergencies. Pooled mean CRP was 4 mg/L before conception peaking in the second trimester at 9.4 mg/L. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was below 4 at all time-points., Conclusions: Pooled rates of most outcomes were better than what had been reported in the literature and within expected rates of those reported for the general population. Pre-conception counselling, planned pregnancies and a tight management in expert centres applying a tailored treatment approach may have contributed to the favourable pregnancy outcomes., Competing Interests: Competing interests: YM: lecture honoraria from Pfizer outside the scope of the submitted work. AS: speaker fees from AbbVie, Amgen, BMS, Celltrion, Janssen, Lilly, Pfizer, Roche, Sanofi, UCB. AM: consulting fees and symposia: AbbVie, BMS, Janssen, MSD, Pfizer, Biogen, Galapagos, Lilly; research grants: UCB France and Pfizer. FF: Grant/research support from UCB Pharma and GSK; speakers bureau for Mepha, Roche and UCB Pharma. The GR2 study has received grants from patient associations (Lupus France; association des Sclérodermiques de France, association Gougerot Sjögren, AFPCA - Association Francophone contre la Polychondrite chronique atrophiante), from the AFM-Telethon, the French Society of Internal Medicine (SNFMI), the French Society of Rheumatology (SFR), the CMEL commission for Research and Innovation of Cochin Hospital, the Ministère de la Santé (the Clinical REsearch Contract – Database CRCBDD17003), FOREUM (Foundation for Research in Rheumatology), ORRICK society (Price Véronique ROUALET) and an unrestricted grant from UCB (the company had no role in the initiation, planning, conduct, data assembly, analysis or interpretation of the study). IH: consulting fees and symposia: Boehringer Ingelheim, Lilly. CR: consulting fees and symposia: AbbVie, Amgen, Astra Zeneca, BMS, Celltrion, GSK, MSD, Novartis, Pfizer, Biogen, Galapagos, Lilly; research grants: Biogen and Lilly. JS: consulting fees and symposia: AbbVie, BMS, Janssen, MSD, Pfizer, Roche, Sandoz, Fresenius Kabi, Galapagos, Lilly; research grants: Roche France, MSD and Pfizer. The remaining authors have no conflicts of interest to declare., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2022
Full Text
View/download PDF

28. Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017.

Author

Richebé P, Coiffier G, Guggenbuhl P, Mulleman D, Couderc M, Dernis E, Deprez V, Salliot C, Urien S, Brault R, Ruyssen-Witrand A, Hoppe E, Chatelus E, Roux CH, Ottaviani S, Baufrere M, Michaut A, Pauvele L, Darrieutort-Laffite C, Wendling D, Coquerelle P, Bart G, Gervais E, Goeb V, Ardizzone M, Pertuiset E, Derolez S, Ziza JM, Flipo RM, Godot S, and Seror R

Abstract

Objectives: To describe current management and outcome of native joint septic arthritis (NJSA) in French rheumatology departments., Methods: For this retrospective, nationwide multicentric study, 127 French rheumatology departments were contacted to report up to 12 cases of NJSA that occurred between 1 January 2016 and 31 December 2017. Characteristics, diagnosis procedures, therapeutic management and outcome were recorded., Results: Overall, 362 patients were included (mean age 64.0±18.6 years, median Charlson comorbidity index 3.5 (0-14)). Knee was the most frequent site (n=160 (38.9%)), and Staphylococcus sp (n=185 (51.4%)), the most frequent pathogen. All patients received antibiotics for a mean duration of 46.8 (±22.0) days, including intravenous route for a mean of 17.2 (±15.4) days. Management was heterogeneous. Surgical procedure was performed in 171 (48.3%), joint immobilisation in 128 (43.8%). During follow-up, 91 (28.3%) patients have had serious complications and 28 (9.2%) of them died. Factors associated with 1-year mortality were age (OR 1.08, 95% CI 1.04 to 1.13; p<0.001), Charlson's index (OR 1.30, 95% CI 1.06 to 1.58; p=0.012), presence of bacteraemia (OR 4.02, 95% CI 1.35 to 11.99; p=0.008), antibiotic use in the previous 3 months (OR 3.32, 95% CI 1.11 to 9.87; p=0.029) and Staphylococcus aureus NJSA compared with Streptococcus sp. NJSA (OR 7.24, 95% CI 1.26 to 41.68, p=0.027). The complete recovery with no adverse joint outcome at 1 year was observed in n=125/278 patients (55.0%)., Conclusion: Prognosis of NJSA remained severe with a high rate of morbimortality. Its management was very heterogeneous. This study highlights the importance of the new French recommendations, published after the completion of the study, in order to facilitate NJSA management., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2022
Full Text
View/download PDF

29. B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.

Author

Felten R, Duret PM, Bauer E, Sedmak N, Djossou JH, Bensalem M, Ardizzone M, Geoffroy M, Fan A, Couderc M, Salmon JH, Messer L, Javier RM, Meyer A, Chatelus E, Sordet C, Pijnenburg L, Fort J, Rinagel M, Walther J, Fabre C, Arnaud L, Sibilia J, Meyer N, Berenbaum F, Chary-Valckenaere I, Soubrier M, Sellam J, and Gottenberg JE

Subjects
Abatacept adverse effects, Administration, Intravenous, Aged, Antibodies, Monoclonal, Humanized adverse effects, B-Lymphocytes, Biological Products administration & dosage, Biological Products therapeutic use, Female, Hospitalization, Humans, Infliximab adverse effects, Male, Middle Aged, Patient Acuity, Risk Factors, Rituximab adverse effects, SARS-CoV-2, Antirheumatic Agents adverse effects, Arthritis drug therapy, Biological Products adverse effects, COVID-19 chemically induced
Abstract

Competing Interests: Competing interests: None declared.

Published
2022
Full Text
View/download PDF

30. Response to: 'Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?' by Coiffier et al .

Author

Couderc M and Dubost JJ

Subjects
Humans, Salivary Glands diagnostic imaging, Autoimmune Diseases, Connective Tissue Diseases, Scleroderma, Systemic complications, Scleroderma, Systemic diagnostic imaging, Sjogren's Syndrome complications, Sjogren's Syndrome diagnostic imaging
Abstract

Competing Interests: Competing interests: None declared.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results